STMN1 and non-small cell lung carcinoma: Interestingly, we found that stathmin pathway levels were highly elevated in NSCLC tumors as compared to normal lung tissues in four different NSCLC datasets73,74 (GSE31547 unpublished) and in > 500 TCGA patients (Fig. 6e).